Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MAB Discovery GmbH

www.mabdiscovery.com

Latest From MAB Discovery GmbH

BioNTech Snaps Up Pancreatic Cancer Antibody, US Infrastructure

Europe’s largest private family-backed biotech adds to its antibody pipeline and its infrastructure in the US with assets from MabVax Therapeutics, in order to pioneer patient-specific immunotherapies for cancer and infections.

 

Deals ImmunoOncology

Deal Watch: Purdue Continues Move Away From Opioids With Alivio Deal

In its continuing efforts to diversify away from opioid pain drugs, Purdue partners on non-opioid program with Alivio. Rigel licenses Tavalisse rights in all indications go to Spain’s Grifols.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • MAB Discovery GmbH
  • Senior Management
  • Stephan Fischer, PhD, CEO
    Birgit Zech, PhD, Head, Bus. Dev.
  • Contact Info
  • MAB Discovery GmbH
    Phone: 89 990 178-0
    Forstenrieder Strasse 8-14
    Neuried, 82061
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register